Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × Ondansetron × Clear all

NCT03572829 2020-07-15

Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC

Phase 2 Completed

Head and Neck Neoplasms, Vomiting